The impact of systemic disease-associated gingival enlargement on pediatric patients.
This article provides an analysis of pediatric systemic disease and the corresponding prescribed medications for selected physical and mental health conditions. The focus is on pediatric oral health, specifically the drug-associated side effect of gingival enlargement. A simple and logical analysis of current pediatric health trends reveals that gingival overgrowth is evident in societies worldwide as a serious epidemic. This article describes the morbidity and risks that are related to drug-associated gingival overgrowth, and proposes a framework of action for treating the side effects of chronic diseases and conditions in pediatric patients.
Nowzari
Hessam
H
Advanced Periodontics, University of Southern California, Los Angeles, California, USA.
Rich
Sandra K
SK
D000662:Amphetamines / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000009:adverse effects; D002547:Cerebral Palsy / Q000150:complications; D002648:Child; D019140:Dental Care for Children; D017742:Dental Care for Chronically Ill; D019214:Gingival Overgrowth / Q000139:chemically induced* / Q000209:etiology / Q000523:psychology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects
D000662:Amphetamines; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents